These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 28376659)

  • 1. Kappa opioid receptor antagonists: A possible new class of therapeutics for migraine prevention.
    Xie JY; De Felice M; Kopruszinski CM; Eyde N; LaVigne J; Remeniuk B; Hernandez P; Yue X; Goshima N; Ossipov M; King T; Streicher JM; Navratilova E; Dodick D; Rosen H; Roberts E; Porreca F
    Cephalalgia; 2017 Jul; 37(8):780-794. PubMed ID: 28376659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel, injury-free rodent model of vulnerability for assessment of acute and preventive therapies reveals temporal contributions of CGRP-receptor activation in migraine-like pain.
    Kopruszinski CM; Navratilova E; Swiokla J; Dodick DW; Chessell IP; Porreca F
    Cephalalgia; 2021 Mar; 41(3):305-317. PubMed ID: 32985222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lateralized kappa opioid receptor signaling from the amygdala central nucleus promotes stress-induced functional pain.
    Nation KM; De Felice M; Hernandez PI; Dodick DW; Neugebauer V; Navratilova E; Porreca F
    Pain; 2018 May; 159(5):919-928. PubMed ID: 29369967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kappa opioid signaling in the central nucleus of the amygdala promotes disinhibition and aversiveness of chronic neuropathic pain.
    Navratilova E; Ji G; Phelps C; Qu C; Hein M; Yakhnitsa V; Neugebauer V; Porreca F
    Pain; 2019 Apr; 160(4):824-832. PubMed ID: 30681985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ubrogepant does not induce latent sensitization in a preclinical model of medication overuse headache.
    Navratilova E; Behravesh S; Oyarzo J; Dodick DW; Banerjee P; Porreca F
    Cephalalgia; 2020 Aug; 40(9):892-902. PubMed ID: 32615788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of kappa-opioid receptor ligands on prepulse inhibition and CRF-induced prepulse inhibition deficits in the rat.
    Tejeda HA; Chefer VI; Zapata A; Shippenberg TS
    Psychopharmacology (Berl); 2010 Jun; 210(2):231-40. PubMed ID: 20232058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulation of serum prolactin links the hypothalamus with female nociceptors to promote migraine.
    Watanabe M; Kopruszinski CM; Moutal A; Ikegami D; Khanna R; Chen Y; Ross S; Mackenzie K; Stratton J; Dodick DW; Navratilova E; Porreca F
    Brain; 2022 Aug; 145(8):2894-2909. PubMed ID: 35325034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of Kappa Opioid Receptor Inactivation Depends on Sex and Cellular Site of Antagonist Action.
    Reichard KL; Newton KA; Rivera ZMG; Sotero de Menezes PM; Schattauer SS; Land BB; Chavkin C
    Mol Pharmacol; 2020 Nov; 98(5):548-558. PubMed ID: 32913138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kappa opioid receptor activation decreases inhibitory transmission and antagonizes alcohol effects in rat central amygdala.
    Gilpin NW; Roberto M; Koob GF; Schweitzer P
    Neuropharmacology; 2014 Feb; 77():294-302. PubMed ID: 24157490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of mu and kappa opioid antagonists on Fos-like immunoreactivity in extended amygdala.
    Carr KD; Kutchukhidze N; Park TH
    Brain Res; 1999 Mar; 822(1-2):34-42. PubMed ID: 10082881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stress-Induced Reinstatement of Nicotine Preference Requires Dynorphin/Kappa Opioid Activity in the Basolateral Amygdala.
    Nygard SK; Hourguettes NJ; Sobczak GG; Carlezon WA; Bruchas MR
    J Neurosci; 2016 Sep; 36(38):9937-48. PubMed ID: 27656031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system.
    Land BB; Bruchas MR; Lemos JC; Xu M; Melief EJ; Chavkin C
    J Neurosci; 2008 Jan; 28(2):407-14. PubMed ID: 18184783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prefrontal cortical kappa-opioid receptor modulation of local neurotransmission and conditioned place aversion.
    Tejeda HA; Counotte DS; Oh E; Ramamoorthy S; Schultz-Kuszak KN; Bäckman CM; Chefer V; O'Donnell P; Shippenberg TS
    Neuropsychopharmacology; 2013 Aug; 38(9):1770-9. PubMed ID: 23542927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. κ-Opioid Receptor Activation in Dopamine Neurons Disrupts Behavioral Inhibition.
    Abraham AD; Fontaine HM; Song AJ; Andrews MM; Baird MA; Kieffer BL; Land BB; Chavkin C
    Neuropsychopharmacology; 2018 Jan; 43(2):362-372. PubMed ID: 28649993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynorphin-kappa opioid receptor activity in the central amygdala modulates binge-like alcohol drinking in mice.
    Anderson RI; Lopez MF; Griffin WC; Haun HL; Bloodgood DW; Pati D; Boyt KM; Kash TL; Becker HC
    Neuropsychopharmacology; 2019 May; 44(6):1084-1092. PubMed ID: 30555162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissociating Motivational From Physiological Withdrawal in Alcohol Dependence: Role of Central Amygdala κ-Opioid Receptors.
    Kissler JL; Walker BM
    Neuropsychopharmacology; 2016 Jan; 41(2):560-7. PubMed ID: 26105136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Species differences in the effects of the κ-opioid receptor antagonist zyklophin.
    Sirohi S; Aldrich JV; Walker BM
    Alcohol; 2016 Mar; 51():43-9. PubMed ID: 26992699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physical presence of nor-binaltorphimine in mouse brain over 21 days after a single administration corresponds to its long-lasting antagonistic effect on κ-opioid receptors.
    Patkar KA; Wu J; Ganno ML; Singh HD; Ross NC; Rasakham K; Toll L; McLaughlin JP
    J Pharmacol Exp Ther; 2013 Sep; 346(3):545-54. PubMed ID: 23853171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissociable effects of kappa-opioid receptor activation on impulsive phenotypes in wistar rats.
    Walker BM; Kissler JL
    Neuropsychopharmacology; 2013 Oct; 38(11):2278-85. PubMed ID: 23689673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization and preclinical evaluation of a protease activated receptor 2 (PAR2) monoclonal antibody as a preventive therapy for migraine.
    Kopruszinski CM; Thornton P; Arnold J; Newton P; Lowne D; Navratilova E; Swiokla J; Dodick DW; Dobson C; Gurrell I; Chessell IP; Porreca F
    Cephalalgia; 2020 Dec; 40(14):1535-1550. PubMed ID: 33131305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.